Thư viện tri thức trực tuyến
Kho tài liệu với 50,000+ tài liệu học thuật
© 2023 Siêu thị PDF - Kho tài liệu học thuật hàng đầu Việt Nam

Tài liệu Báo cáo khoa học: Peroxiredoxin II functions as a signal terminator for H2O2-activated
Nội dung xem thử
Mô tả chi tiết
Peroxiredoxin II functions as a signal terminator
for H2O2-activated phospholipase D1
Nianzhou Xiao, Guangwei Du and Michael A. Frohman
Department of Pharmacology and the Center for Developmental Genetics, University Medical Center at Stony Brook, NY, USA
Mammalian phospholipase D (PLD) is a signal-transducing enzyme that hydrolyzes PtdCho to generate the
membrane-bound lipid signal phosphatidic acid (PA)
(reviewed in [1,2]). PA is a second messenger and can
be further converted into diacylglycerol. PLD is indirectly activated in response to cellular stimulation by
various extracellular agonists including hormones,
growth factors, neurotransmitters, adhesion molecules,
cytokines and physical stimuli. The direct mechanism
by which PLD is activated involves physical interaction with protein kinase C (PKC) and the ADP-ribosylation factor (ARF) and RhoA small GTPase families.
A well-studied role for PLD in stimulation of
NADPH during respiratory oxidative burst has been
described by may groups [3–6] (reviewed in [7]). PLD
functions both directly, by generating PA, which binds
to and stimulates the p47(phox) component of the
NADPH oxidase complex [5,8], and by conversion
of some of the PA into diacylglycerol. Diacylglycerol
recruits PKC to the plasma membrane, which is also
required for NADPH activation [9,10]. Once NADPH
oxidase is activated, it generates H2O2, which can function to kill intracellular bacteria and play pro-apoptotic or anti-apoptotic roles depending on the cellular
context. In addition, H2O2 stimulates PLD activity by
a poorly understood, probably indirect, mechanism
involving tyrosine kinases and PKC [11–13]. This creates a runaway positive feedback cycle: PLD activation
promotes H2O2 production and PKC recruitment,
which leads to even more PLD activity. This paper
reports the identification of a cellular mechanism by
which this positive feedback cycle may be regulated
and terminated.
In addition to the extensively documented interactions between PLD1 and the proteins (PKC, ARF and
RhoA) that stimulate it directly [14–18], interactions
involving other proteins, such as actin, protein kinase N,
casein-kinase-2-like serine kinase and amphiphysin,
Keywords
hydrogen peroxide; peroxiredoxin II;
phosphatidic acid; phospholipase D1; PMA
Correspondence
M. Frohman, Center for Developmental
Genetics, 438 CMM, Stony Brook, NY
11794-5140, USA
Fax: +1 631 632 1692
Tel: +1 631 632 1476
E-mail: [email protected]
(Received 4 May 2005, revised 3 June
2005, accepted 8 June 2005)
doi:10.1111/j.1742-4658.2005.04809.x
Phospholipase D1 (PLD1) is a signal-transduction regulated enzyme which
regulates several cell intrinsic processes including activation of NAPDH
oxidase, which elevates intracellular H2O2. Several proteins have been
reported to interact with PLD1 in resting cells. We sought to identify proteins that interact with PLD1 after phorbol 12-myristate 13-acetate (PMA)
stimulation. A novel interaction with peroxiredoxin II (PrxII), an enzyme
that eliminates cellular H2O2, which is a known stimulator of PLD1, was
identified by PLD1-affinity pull-down and MS. PMA stimulation was confirmed to promote physical interaction between PLD1 and PrxII and to
cause PLD1 and PrxII to colocalize subcellularly. Functional significance
of the interaction was suggested by the observation that over-expression of
PrxII specifically reduces the response of PLD1 to stimulation by H2O2.
These results indicate that PrxII may have a signal-terminating role for
PLD1 by being recruited to sites containing activated PLD1 after cellular
stimulation involving production of H2O2.
Abbreviations
HA, hemagglutinin; MobA, molybdopterin guanine dinucleotide biosynthesis protein AI; PA, phosphatidic acid; PLD, phospholipase D; PKC,
protein kinase C; PMA, phorbol-12-myristate 13-acetate; PrxII, peroxiredoxin II.
FEBS Journal 272 (2005) 3929–3937 ª 2005 FEBS 3929